YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Going Long vs Going for the Sale


December 20, 2012 | Do biotechs today have a long term plan or vision? Should they? With Big Pharma seemingly always on the hunt for new technologies and targets to snatch up, do you need a long term plan? Or is an M&A goal good enough? Xconomy
View Next Related Story
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.